SAN DIEGO, April 1, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced positive topline data from a Phase 1 clinical study evaluating controlled-release delivery profiles ...
SAN FRANCISCO, Feb. 10, 2026 /PRNewswire/ -- Arena today announced the launch of its Academic Partnerships Program, a new initiative aimed at advancing research in AI evaluation, rankings, and ...